Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP827815.RAWIgy7B2WisO2OhItYl8o8rsR6Xz2IhIdx3C9UypLFUs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP827815.RAWIgy7B2WisO2OhItYl8o8rsR6Xz2IhIdx3C9UypLFUs130_assertion type Assertion NP827815.RAWIgy7B2WisO2OhItYl8o8rsR6Xz2IhIdx3C9UypLFUs130_head.
- NP827815.RAWIgy7B2WisO2OhItYl8o8rsR6Xz2IhIdx3C9UypLFUs130_assertion description "[Mutations of the KRAS, BRAF, and PIK3CA genes have been reported in colorectal cancer (CRC), associated with resistance to epidermal growth factor receptor (EGFR)-targeted monoclonal antibody therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP827815.RAWIgy7B2WisO2OhItYl8o8rsR6Xz2IhIdx3C9UypLFUs130_provenance.
- NP827815.RAWIgy7B2WisO2OhItYl8o8rsR6Xz2IhIdx3C9UypLFUs130_assertion evidence source_evidence_literature NP827815.RAWIgy7B2WisO2OhItYl8o8rsR6Xz2IhIdx3C9UypLFUs130_provenance.
- NP827815.RAWIgy7B2WisO2OhItYl8o8rsR6Xz2IhIdx3C9UypLFUs130_assertion SIO_000772 20652941 NP827815.RAWIgy7B2WisO2OhItYl8o8rsR6Xz2IhIdx3C9UypLFUs130_provenance.
- NP827815.RAWIgy7B2WisO2OhItYl8o8rsR6Xz2IhIdx3C9UypLFUs130_assertion wasDerivedFrom befree-2016 NP827815.RAWIgy7B2WisO2OhItYl8o8rsR6Xz2IhIdx3C9UypLFUs130_provenance.
- NP827815.RAWIgy7B2WisO2OhItYl8o8rsR6Xz2IhIdx3C9UypLFUs130_assertion wasGeneratedBy ECO_0000203 NP827815.RAWIgy7B2WisO2OhItYl8o8rsR6Xz2IhIdx3C9UypLFUs130_provenance.